These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia. Schapel GJ; Edwards KD; Neale FC Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384 [No Abstract] [Full Text] [Related]
5. A pathophysiologic approach to managing hyperlipemia. Hazzard WR Am Fam Physician; 1976 Aug; 14(2):78-87. PubMed ID: 941821 [TBL] [Abstract][Full Text] [Related]
6. Treatment of essential hyperlipidaemia. Fredrickson DS; Levy RI Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
7. The investigation and treatment of hyperlipidaemia in general practice. Tierney E Practitioner; 1975 Mar; 214(1281):393-6. PubMed ID: 1144258 [TBL] [Abstract][Full Text] [Related]
15. The pediatrician's role in genetic hyperlipidemias. Schleman MM Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289 [No Abstract] [Full Text] [Related]
16. Letter: Screening for hyperlipidaemia in childhood. Lloyd JK; Fosbrooke AS; West R; Wolff OH Br Med J; 1975 Jan; 1(5948):35. PubMed ID: 1120225 [No Abstract] [Full Text] [Related]
17. [Therapy of hyperlipidemias]. Sailer S Wien Klin Wochenschr; 1971 Oct; 83(39):691-4. PubMed ID: 5165100 [No Abstract] [Full Text] [Related]